SMYD2 and cancer: Increased activity of the SMYD2 protein is associated with more aggressive growth in several cancer types, and Kwangho Kim of the Korea Research Institute of Bioscience and Biotechnology, Daejeon, and colleagues have linked heightened SMYD2 expression with poor prognosis in NSCLC patients.